Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
  • Address and mission.
  • Equipment/Knowhow.
  • Staff.
  • Projects.
  • Publications.
  • Advised theses.
  • Project partners.
  • Sponsors.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Department of Paediatrics and Adolescent Medicine

Division of General Paediatrics

Project partners

Medizinische Universität Innsbruck (MUI), Innsbruck, Austria

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Medizinische Universität Wien (MUW), Spitalgasse 23, 1090 Wien, Austria

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

University Libre de Bruxelles, Brüssel, Belgium

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Kobenhavns Universitet, Denmark

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

NovoNordisk, Denmark

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Region Hovedstaden, Kongens Vaenge 2, 3400 Hillerod, Denmark

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Helsingin Yliopisto, Helsinki, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Turku University, Turku, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

University of Oulu, Finland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Biomerieux SA, Marcy l`Etoile, France

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

HEVA HEOR (HEV) SARL,, Lyon, France

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Institut de la Sante de la Recherche Medicale (INSERM), France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Sanofi-Aventis Recherche & Development, Chilly, France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Sarl Endocells, Paris, France

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Hannoversche Kinderheilanstalt, Hannover, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Helmholtz Zentrum München-Deutsches Forschungszentrum für Gesundheit und Umwelt, Landstraße 1, 85764 Neuherberg, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Ludwig-Maximilians-Universität München, München, Germany

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Technische Universität Dresden, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Universität Bern, Germany

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Universität Leipzig, Leipzig, Germany

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Universität Ulm, Ulm, Germany

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Ethniko kai Kapodistriako Panepistimio Athinion, Athen, Greece

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Novartis Vaccines and Diagnostics, Via Fiorentina 1, 53100 Siena, Italy

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Università degli Studi "G. d`Annunzio", Chieti-Pescara, Chieti, Italy

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

University of Pisa, Pisa, Italy

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Riga stradings University, Latvia

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Centre Hospitalier de Luxembourg, Luxembourg

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Academisch Medisch Centrum, Meibergdreef 9,, 1105AZ Amsterdam, Netherlands

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Academisch Ziekenhuis bij de Universiteit van Amsterdam, Amsterdam, Netherlands

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Academisch Ziekenhuis Leiden, Netherlands

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Erasmus Medical Center Rotterdam, Netherlands

Whole Genome Screening des Menschen bei der Menigokokkensepsis
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Land Steiermark, Graz, Austria
• Duration: 17.07.2008-31.05.2010
   .

Erasmus Universitair Medisch Centrum Rotterdam, Netherlands

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Katholieke Universiteit Leuven, Oude Markt 13, 3000 Leuven, Netherlands

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Stichting Katholieke Universiteit - the Radboud University Nijmegen Medical Centre, Netherlands

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Universitetet i Oslo, Oslo, Norway

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Slaski Uniwersytet Medyczny w Katowicach, Katowice, Poland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Genome Institute of Singapore-BIOMEDICAL SCIENCES INSTITUTES, Singapore

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

University Clinical Center Ljubljana, Department of Otorhinolaryngology and Cervicofacial Surgery, Ljubljana, Slovenia

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Univerza v Ljubljani, Ljubljana, Slovenia

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Servizio Galego de Saude, Edificio Administrativo San Lázaro, 15703 Santiago de Compostela, Spain

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

DIASEND AB, Askim, Sweden

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Universite de Lausanne, Lausanne, Switzerland

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Eli Lilly and Company Ltd, Lilly House Priestley Road, RG24 9NL Basingstoke, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Glaxosmithkline Research and Development LTD., Great West Road 980 Brentford, TW8 9GS Middlesex, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Imperial College London, London, United Kingdom

Whole Genome Screening des Menschen bei der Menigokokkensepsis
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Land Steiermark, Graz, Austria
• Duration: 17.07.2008-31.05.2010
   .

Imperial College London Consultants, Sherfield Building, Exhibition Road, SW7 2AZ London, United Kingdom

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Imperial College of Science, Technology and Medicine, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Kings College London, London, United Kingdom

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

London School of Hygiene and tropical Medicine, Keppel Street, WC1E7HT London, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

Medical Research Council, 2nd Floor David Phillips Building,Polaris House, North Star Avenue, SN2 1FL Swindon, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

Micropathology Limited, Sir William Lyons Road, CV4 7EZ Coventry, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Oxford Gene Technology (Operations) Ltd, Begbroke Science Park, Sandy Lane, Yarnton, OX5 PF Oxford, United Kingdom

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

The Chancellor, Masters and Scholars of the University of Cambridge, Cambridge, United Kingdom

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

The Chancellor, Masters and Scholars of the University of Oxford, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST, Leeds, United Kingdom

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

University of Edinburgh, Edinburgh, United Kingdom

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

University of Liverpool, Brownlow Hill, Foundation Building 765, L69 7ZX Liverpool, United Kingdom

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

The genetic basis of meningococcal and other life threatening bacterial infections of childhood
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (FP-7)
• Duration: 01.12.2011-31.05.2017
   .

Personalised Risk assessment in febrile illness to Optimise Real-life Management across the European Union
• Project type: EN: Forschungsförderung.
• Project Leader: Zenz Werner
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2016-31.12.2020
   .

JAEB CENTER FOR HEALTH RESEARCH FOUNDATION INC, Tampa, United States (USA)

Artificial Pancreas in children with type 1 Diabetes between 1 to 7 years of Age.
• Project type: EN: Forschungsförderung.
• Project Leader: Fröhlich-Reiterer Elke
• MUG Research Units: Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.01.2017-31.12.2021
   .

JDRF International, New York, United States (USA)

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

The Leona M. and Harry B. Helmsley Charitable Trust, New York, United States (USA)

Translational approaches to disease modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting Type 1 diabetes
• Project type: EN: Forschungsförderung.
• Project Leader: Pieber Thomas
• MUG Research Units: Division of Endocrinology and Diabetology ; Division of General Paediatrics ;
• Funded by: Europäische Kommission, Rue de la Loi, Brussels, Belgium
• Programme: EU (Horizon 2020)
• Duration: 01.11.2015-31.10.2023
   .

↑ Top of page / Navigation

© Med Uni Graz • Imprint